TEM
NASDAQ · Life Sciences Tools & Services
Tempus Ai Inc
$46.76
-2.07 (-4.24%)
Financial Highlights (FY 2026)
Revenue
1.03B
Net Income
-1,050,007,940
Gross Margin
55.0%
Profit Margin
-101.8%
Rev Growth
+39.1%
D/E Ratio
7.73
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 55.0% | 55.0% | 44.0% | 44.0% |
| Operating Margin | -99.7% | -89.7% | 20.9% | 23.7% |
| Profit Margin | -101.8% | -96.7% | 17.8% | 17.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.03B | 741.79M | 4.22B | 4.70B |
| Gross Profit | 566.93M | 407.69M | 1.85B | 2.07B |
| Operating Income | -1,028,132,628 | -665,410,157 | 880.21M | 1.12B |
| Net Income | -1,050,007,940 | -679,567,917 | 751.80M | 807.44M |
| Gross Margin | 55.0% | 55.0% | 44.0% | 44.0% |
| Operating Margin | -99.7% | -89.7% | 20.9% | 23.7% |
| Profit Margin | -101.8% | -96.7% | 17.8% | 17.2% |
| Rev Growth | +39.1% | +39.1% | +21.7% | +17.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 4.72B | 4.72B | 4.60B | 4.62B |
| Total Equity | 611.03M | 611.03M | 6.78B | 7.47B |
| D/E Ratio | 7.73 | 7.73 | 0.68 | 0.62 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -961,805,989 | -657,065,791 | 1.29B | 1.47B |
| Free Cash Flow | — | — | 351.34M | 441.08M |